Therapeutic potential of nicotinamide adenine dinucleotide (NAD)

被引:13
|
作者
Arenas-Jal, Marta [1 ,2 ]
Sune-Negre, J. M. [1 ]
Garcia-Montoya, Encarna [1 ]
机构
[1] Univ Barcelona, Pharm & Pharmaceut Technol Dept, Fac Pharm & Food Sci, Barcelona, Spain
[2] Autonomous Univ Barcelona, ICN2 Catalan Inst Nanosci & Nanotechnol, Bellaterra, Barcelona, Spain
关键词
NAD; Metabolism; Therapeutic potential; Drug discovery; Supplementation; FATTY LIVER-DISEASE; NLRP3; INFLAMMASOME; CISPLATIN OTOTOXICITY; CALORIC RESTRICTION; OXIDATIVE STRESS; CELL-SURVIVAL; LIFE-SPAN; METABOLISM; SIRT1; CD38;
D O I
10.1016/j.ejphar.2020.173158
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nicotinamide adenine nucleotide (NAD) is a small ubiquitous hydrophilic cofactor that participates in several aspects of cellular metabolism. As a coenzyme it has an essential role in the regulation of energetic metabolism, but it is also a cosubstrate for enzymes that regulate fundamental biological processes such as transcriptional regulation, signaling and DNA repairing among others. The fluctuation and oxidative state of NAD levels regulate the activity of these enzymes, which is translated into marked effects on cellular function. While alterations in NAD homeostasis are a common feature of different conditions and age-associated diseases, in general, increased NAD levels have been associated with beneficial health effects. Due to its therapeutic potential, the interest in this molecule has been renewed, and the regulation of NAD metabolism has become an attractive target for drug discovery. In fact, different approaches to replenish or increase NAD levels have been tested, including enhancement of biosynthesis and inhibition of NAD breakdown. Despite further research is needed, this review provides an overview and update on NAD metabolism, including the therapeutic potential of its regulation, as well as pharmacokinetics, safety, precautions and formulation challenges of NAD supplementation.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Effect of β-nicotinamide adenine dinucleotide (β-NAD) on in vivo bladder function in mice
    Hiragata, Shiro
    Chancellor, Michael B.
    de Groat, William C.
    Mutafova-Yamboiieva, Violeta N.
    Yoshimura, Naoki
    JOURNAL OF UROLOGY, 2007, 177 (04): : 83 - 83
  • [22] Viewing teratogens through the lens of nicotinamide adenine dinucleotide (NAD plus )
    Mark, Paul R.
    Dunwoodie, Sally L.
    BIRTH DEFECTS RESEARCH, 2022, 114 (20): : 1313 - 1323
  • [23] SPECIFIC COUPLING OF NICOTINAMIDE ADENINE-DINUCLEOTIDE (NAD) TO POLYMER SUPPORTS
    GRENNER, G
    SCHMIDT, H
    ZEITSCHRIFT FUR KLINISCHE CHEMIE UND KLINISCHE BIOCHEMIE, 1974, 12 (05): : 243 - 243
  • [24] MEASUREMENT OF NICOTINAMIDE ADENINE DINUCLEOTIDE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE IN TOMATO LEAVES
    GRAHAM, JS
    HAWKER, JS
    PLANT PHYSIOLOGY, 1962, 37 (06) : 765 - &
  • [25] Nicotinamide adenine dinucleotide homeostasis and signalling in heart disease: Pathophysiological implications and therapeutic potential
    Mericskay, Mathias
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2016, 109 (03) : 207 - 215
  • [26] The effects of nicotinamide adenine dinucleotide in cardiovascular diseases: Molecular mechanisms, roles and therapeutic potential
    Zhang, Xiaokai
    Zhang, Yang
    Sun, Aijun
    Ge, Junbo
    GENES & DISEASES, 2022, 9 (04) : 959 - 972
  • [27] Pharmacology and Potential Implications of Nicotinamide Adenine Dinucleotide Precursors
    She, Jing
    Sheng, Rui
    Qin, Zheng-Hong
    AGING AND DISEASE, 2021, 12 (08): : 1879 - 1897
  • [28] Inhibition of nicotinamide adenine dinucleotide (NAD) production is a potent therapeutic strategy to inactivate homologous recombination in cancer cells
    Sheida, Sadaf Valeh
    Peterlini, Thibaut
    Thomas, Melissa
    Poirier, Guy
    Masson, Jean-Yves
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (06)
  • [29] Metal hydrides as the pre-biotic cousins of nicotinamide adenine dinucleotide (NAD)
    Pereira, Delfina
    Leethaus, Jana
    Beyazay, Tugce
    Vieira, Andrey do Nascimento
    Kleinermanns, Karl
    Tueysuez, Harun
    Martin, William F.
    Preiner, Martina
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2022, 1863 : 51 - 52
  • [30] 'Congenital Nicotinamide adenine dinucleotide (NAD) Deficiency Disorder treated with niacin supplementation'
    Cueto-Gonzalez, A. M.
    Arevalo, S.
    Del Toro, M.
    Giralt, G.
    Creus, A.
    Torres, M.
    Valenzuela, I.
    Abuli, A.
    Tizzano, E.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 294 - 294